Growing community of inventors

Philadelphia, PA, United States of America

Michael Klichinsky

Average Co-Inventor Count = 3.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 10

Michael KlichinskyCarl H June (9 patents)Michael KlichinskySaar Gill (9 patents)Michael KlichinskyNicholas R Anderson (2 patents)Michael KlichinskyNicholas G Minutolo (2 patents)Michael KlichinskyMichael Klichinsky (11 patents)Carl H JuneCarl H June (132 patents)Saar GillSaar Gill (31 patents)Nicholas R AndersonNicholas R Anderson (2 patents)Nicholas G MinutoloNicholas G Minutolo (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Pennsylvania (9 from 2,597 patents)

2. Carisma Therapeutics Inc. (2 from 2 patents)


11 patents:

1. 11739297 - Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor

2. 11498954 - Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

3. 11407805 - Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

4. 11359002 - Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

5. 11332511 - Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

6. 11325963 - Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

7. 11319358 - Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

8. 11312939 - Constructs for chimeric antigen receptors

9. 11306133 - Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

10. 11306134 - Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

11. 11034749 - Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…